Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHEK1 | O14757 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | AURKA | O14965 | 1/20 | 0.31 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.31 |
| ▸ | ABL1 | P00519 | 1/20 | 0.31 |
| ▸ | CSF1R | P07333 | 1/20 | 0.31 |
| ▸ | RET | P07949 | 1/20 | 0.31 |
| ▸ | MET | P08581 | 1/20 | 0.31 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.31 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.31 |
| ▸ | FLT1 | P17948 | 1/20 | 0.31 |
| ▸ | LTK | P29376 | 1/20 | 0.31 |
| ▸ | GRK5 | P34947 | 1/20 | 0.31 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.31 |
| ▸ | CDK8 | P49336 | 1/20 | 0.31 |
| ▸ | CLK2 | P49760 | 1/20 | 0.31 |
| ▸ | CDK7 | P50613 | 1/20 | 0.31 |
| ▸ | CDK9 | P50750 | 1/20 | 0.31 |
| ▸ | NEK2 | P51955 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5363339 | 0.79 | DAO (0.32) | CHEK1AURKAMAP4K4ABL1CSF1R | |
| SCHEMBL20258124 | 0.70 | LMNA (0.34) | CHEK1CA1L3MBTL1AURKAMAP4K4 | |
| SCHEMBL29955393 | 0.65 | KDM4E (0.46) | CA1RET | |
| SCHEMBL4471035 | 0.65 | KDM4E (0.40) | L3MBTL1 | |
| SCHEMBL3284250 | 0.65 | HAVCR2 (0.36) | CA1 | |
| SCHEMBL3579630 | 0.65 | FABP3 (0.42) | — | |
| SCHEMBL7124498 | 0.64 | BRD4 (0.38) | L3MBTL1MAP2K1BTK | |
| SCHEMBL16510896 | 0.64 | KDM4E (0.35) | FLT1 | |
| SCHEMBL3152040 | 0.64 | ALDH1A1 (0.35) | CHEK1L3MBTL1AURKAMAP4K4ABL1 | |
| SCHEMBL8194397 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7060822-B1 | 2-pyrazolin-5-ones | ABBOTT GMBH & CO. KG (DE) | 2006-06-13 | — | — | US | disclosed |
| CN-1193026-C | Z-pyrazoline-5-ones | BASF AG (DE) | 2005-03-16 | — | — | CN | disclosed |
| US-6797825-B2 | 1,3-DIHYDRO-2H-INDOL- 2-ONE DERIVATIVES | ABBOTT LABORATORIES | 2004-09-28 | — | — | US | disclosed |
| EP-1453800-A2 | PROTEIN KINASE INHIBITORS | Abbott Laboratories (US) | 2004-09-08 | — | — | EP | disclosed |
| US-20030162785-A1 | Protein kinase inhibitors | ABBVIE INC. | 2003-08-28 | — | — | US | disclosed |
| US-20030119839-A1 | Protein kinase inhibitors | ABBOTT LABORATORIES | 2003-06-26 | — | — | US | disclosed |
| WO-2003051838-A2 | PROTEIN KINASE INHIBITORS | ABBOTT LABORATORIES (US) | 2003-06-26 | — | — | WO | disclosed |
| CN-1377346-A | Z-pyrazoline-5-ones | BASF AG (DE) | 2002-10-30 | — | — | CN | disclosed |
| EP-1218373-A2 | 2-PYRAZOLIN-5-ONES AS TYROSINE KINASE INHIBITORS | BASF AKTIENGESELLSCHAFT (DE) | 2002-07-03 | — | — | EP | disclosed |
| WO-2001009121-A2 | 2-PYRAZOLIN-5-ONES_AS TYROSINE KINASE INHIBITORS | BASF AKTIENGESELLSCHAFT (DE) | 2001-02-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030162785-A1 | Protein kinase inhibitors | MAP3K20, MAP3K1, MAP3K6 | CHEK1 139/4885CA1 3982/4885L3MBTL1 3069/4885 |
| US-20030119839-A1 | Protein kinase inhibitors | MAP3K20, MAP3K1, MAP3K6 | CHEK1 139/4885CA1 3982/4885L3MBTL1 3069/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.